Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Systemic Mastocytosis With an Associated Hematologic Neoplasm × avapritinib × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Leukemia, Myeloid, Acute 5 Recurrence 2 Mastocytosis, Systemic 2 Leukemia, Mast-Cell 2 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Neoplasm, Residual 1 Core Binding Factor Acute Myeloid Leukemia 1

Interventions

decitabine and cedazuridine drug combination 1 avapritinib 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06327685 2026-01-08

Avapritinib With Decitabine in Patients With SM-AHN

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Recruiting

MyeloidOther hematologic neoplasm

Systemic Mastocytosis With an Associated Hematologic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡